Let’s dig into the relative performance of Vertex Pharmaceuticals (NASDAQ:VRTX) and its peers as we unravel the now-completed Q4 therapeutics earnings season. Over the next few years, therapeutic ...
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...
PTC’s (NASDAQ:PTC) software-as-service platform helps engineers and designers create and test products before manufacturing.